GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Sunhere Pharmaceutical Excipients Co Ltd (SZSE:300452) » Definitions » Research & Development

Anhui Sunhere Pharmaceutical Excipients Co (SZSE:300452) Research & Development : ¥40.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Anhui Sunhere Pharmaceutical Excipients Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Anhui Sunhere Pharmaceutical Excipients Co's Research & Development for the three months ended in Sep. 2024 was ¥6.8 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ¥40.0 Mil.


Anhui Sunhere Pharmaceutical Excipients Co Research & Development Historical Data

The historical data trend for Anhui Sunhere Pharmaceutical Excipients Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Sunhere Pharmaceutical Excipients Co Research & Development Chart

Anhui Sunhere Pharmaceutical Excipients Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.19 18.12 26.80 34.43 41.95

Anhui Sunhere Pharmaceutical Excipients Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.44 11.28 11.78 10.16 6.80

Anhui Sunhere Pharmaceutical Excipients Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥40.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Sunhere Pharmaceutical Excipients Co  (SZSE:300452) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Anhui Sunhere Pharmaceutical Excipients Co Research & Development Related Terms

Thank you for viewing the detailed overview of Anhui Sunhere Pharmaceutical Excipients Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Sunhere Pharmaceutical Excipients Co Business Description

Traded in Other Exchanges
N/A
Address
Huainan Economic and Technological Development Zone, Anhui Province, Huainan, CHN, 232008
Anhui Sunhere Pharmaceutical Excipients Co Ltd is engaged in the research, development, production, and sales of pharmaceutical excipients. It is a pharmaceutical excipient manufacturer and is the oral product's producer in China. The company's products are cover fillers, adhesives, disintegrants, lubricants, coating materials and other common oral solid preparations.
Executives
Hu Hao Directors, Directors, and Executives
Zhu Tang Dong Supervisors
Liu Zi Hu Executives
Pan Li Sheng Directors, executives
Song Dao Cai Executives

Anhui Sunhere Pharmaceutical Excipients Co Headlines

No Headlines